Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Tommy Tsang Cheung, Tu H Mai, Yen Lin Chia, Desmond YH Yap, Chi-Ho Lee, Cecil Chi-Keung Chen, Ying Huang, Yuwen Jin, James Johnston, Viktoria Werkström, Yuhui Yao, Xiaoyun Ge & Wenying Zheng. (2023) Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants. Drug Design, Development and Therapy 17, pages 209-218.
Read now
Read now
Laren D Tan, Nolan Nguyen, Abdullah Alismail & Mario Castro. (2022) Management of Uncontrolled Asthma: A Framework for Novel and Legacy Biologic Treatments. Journal of Asthma and Allergy 15, pages 875-883.
Read now
Read now
Saad AlShareef, Christine F McDonald & Joy Lee. (2022) Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma. Journal of Asthma and Allergy 15, pages 209-217.
Read now
Read now
M. B. de Graaff, S. A. Bendien & H. M. van de Bovenkamp. (2022) ‘Like a fish on dry land’: an explorative qualitative study into severe asthma and the impact of biologicals on patients’ everyday life. Journal of Asthma 59:5, pages 980-988.
Read now
Read now
Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Read now
Kim Jackson & Sami L. Bahna. (2020) Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases. Expert Review of Clinical Immunology 16:3, pages 311-319.
Read now
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Jaymin B Morjaria, Rosalia Emma, Virginia Fuochi, Riccardo Polosa & Massimo Caruso. (2019) An evaluation of mepolizumab for the treatment of severe asthma. Expert Opinion on Biological Therapy 19:6, pages 491-500.
Read now
Read now
Articles from other publishers (15)
Joan Reibman, Laren Tan, Chris Ambrose, Yen Chung, Pooja Desai, Jean-Pierre Llanos, Meghan Moynihan & Joseph Tkacz. (2021) Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Annals of Allergy, Asthma & Immunology 127:3, pages 318-325.e2.
Crossref
Crossref
Tadeusz P. Karcz, Gregory S. Whitehead, Keiko Nakano, Hideki Nakano, Sara A. Grimm, Jason G. Williams, Leesa J. Deterding, Kenneth A. Jacobson & Donald N. Cook. (2021) UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia. Journal of Clinical Investigation 131:7.
Crossref
Crossref
Gregory Livshits & Alexander Kalinkovich. (2021) Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacological Research 164, pages 105340.
Crossref
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Crossref
Toa Ookawara, Ryota Aihara, Ai Morimoto, Naoki Iwashita, Keigo Kurata, Yoshiichi Takagi, Atsushi Miyasaka, Masayo Kushiro, Shiro Miyake & Tomoki Fukuyama. (2021)
Acute and Subacute Oral Toxicity of Deoxynivalenol Exposure in a
Dermatophagoides farinae
-Induced Murine Asthma Model
. Toxicological Sciences 179:2, pages 229-240.
Crossref
Crossref
Hitoshi Tajima, Risako Tajiki‐Nishino, Yuko Watanabe, Keigo Kurata & Tomoki Fukuyama. (2020) Activation of aryl hydrocarbon receptor by benzo[a]pyrene increases interleukin 33 expression and eosinophil infiltration in a mouse model of allergic airway inflammation. Journal of Applied Toxicology 40:11, pages 1545-1553.
Crossref
Crossref
Andras Bikov, Ipek Kivilcim Oğuzülgen, Ilaria Baiardini, Marco Contoli, Alexander Emelyanov, Omar Fassio, Juan Carlos Ivancevich, Igor Kaidashev, Krzysztof Kowal, Marina Labor, Lies Lahousse, Stefan Mihaicuta, Silviya Novakova, Alicia Padilla Galo, Alexander Simidchiev, Angelica Tiotiu, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Nelson Rosario, Pierachille Santus, Fulvio Braido, Carmen Ardelean, Hector Badellino, Ariel Blua, Antonio Castillo, E. Carpagnano Giovanna, J. Chong-Neto Herberto, F. Daniel Colodenco, Dario Md Colombaro, Jaime Correia-De-Sousa, Fabiano Di Marco, Kunio Dobashi, Rocio Garcia, René Maximiliano Gomez, Olecsandr Gopko, Guillermo Guidos, Martina Hajduk, Joanna Hermanowicz-Salamon, Enrico Heffler, Bulent Karadag, Ali F. Kalyoncu, Metin Keren, Lykorguos Kolilekas, Marcelina Kocwin, Borislava Krusheva, Désirée Larenas Linnemann, Irine Litovchenko, A. Marcipar, L.E. Meza, D. Nedeva, P. Novakova, D. Plavec, S. Popović-Grle, F. Puggioni, L. Pur Oziygit, N. Rodrigez, D. Ryan, I. Ruzsics, N. Scichilone, F. Serpa, P. Steiropoulos, P. Solidoro, M. Turkalj, T. Umanets, C.F. Victorio, J.M. Zubeldia, V. Yachnyk & M. Zitt. (2020) Beliefs and preferences regarding biological treatments for severe asthma. World Allergy Organization Journal 13:7, pages 100441.
Crossref
Crossref
Grzegorz Kardas, Piotr Kuna & Michał Panek. (2020) Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling. Frontiers in Immunology 11.
Crossref
Crossref
Diego Bagnasco, Alessandro Massolo, Marco Bonavia, Luisa Brussino, Caterina Bucca, Marco Caminati, Giorgio Walter Canonica, Cristiano Caruso, Maria D’Amato, Laura De Ferrari, Giuseppe Guida, Enrico Heffler, Carlo Lombardi, Francesco Menzella, Manlio Milanese, Giovanni Paoletti, Anna Maria Riccio, Giovanni Rolla, Gianenrico Senna, Elisa Testino & Giovanni Passalacqua. (2020) The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life. Allergy 75:6, pages 1460-1463.
Crossref
Crossref
Arash R. Safavi & Michael P. Platt. (2020) Biologic Therapeutics and Their Role in Allergic Disease of the Unified Airway. Current Otorhinolaryngology Reports 8:2, pages 185-190.
Crossref
Crossref
Steve Chaplin. (2020) Monoclonal antibodies for the treatment of severe asthma. Prescriber 31:3, pages 23-28.
Crossref
Crossref
Stefan Uhlig, Michael Dreher & Christian Martin. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1
7
.
Corrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, Giuseppe Francesco Rago, Claudia Crimi, Rosa Terracciano & Girolamo Pelaia. (2019) Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose. Pulmonary Pharmacology & Therapeutics 58, pages 101830.
Crossref
Crossref
Jung-Eun Kim, Keunok Jung, Jeong-Ah Kim, Seung-Hyun Kim, Hae-Sim Park & Yong-Sung Kim. (2019) Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity. Scientific Reports 9:1.
Crossref
Crossref
Corrado Pelaia, Maria Teresa Busceti, Sabina Solinas, Rosa Terracciano & Girolamo Pelaia. (2018) Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study. Pulmonary Pharmacology & Therapeutics 53, pages 1-5.
Crossref
Crossref